Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideABTAbbott Laboratories
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | ABT | TMO |
|---|
| Close | 106.20 | 697.00 |
| Market Cap | $184B | $258B |
| 1M | +7.46% | +3.25% |
| P/E (TTM) | 39.1 | 36.4 |
| Forward P/E | 17.6 | 24.6 |
| P/E 5-Yr Percentile | 99 | 78 |
| P/S | 3.8 | 5.4 |
| P/B | 3.6 | 4.7 |
| Dividend Yield | 1.98% | 0.29% |
| Latest Quarter Revenue | $11.2B | $12.1B |
| Revenue YoY | +7.8% | +9.1% |
| Gross Margin | 56.2% | — |
| Latest Quarter EPS | 0.61 | 4.64 |
| Avg Post-Earnings Move | ±1.6% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.71% | 1.82% |
| 90-Day Net Insider Buying | −$46.9M | −$40.3M |
ABT · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
